Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,879,583 papers from all fields of science
Search
Sign In
Create Free Account
CY 1503
Known as:
CY-1503
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Oligosaccharides
SLeX-OS
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia.
M. Schermerhorn
,
Daniel P. Nelson
,
E. Blume
,
L. Phillips
,
J. Mayer
Annals of Thoracic Surgery
2000
Corpus ID: 24727226
1999
1999
Selectin blockade reduces neutrophil interaction with platelets at the site of deep arterial injury by angioplasty in pigs.
Y. Merhi
,
P. Provost
,
P. Chauvet
,
J. Théorêt
,
M. Phillips
,
J. Latour
Arteriosclerosis, Thrombosis and Vascular Biology
1999
Corpus ID: 12890635
The adhesion of neutrophils to damaged arterial surfaces is increased in the presence of platelets by a mechanism implicating…
Expand
1999
1999
Effect of sialyl Lewis(x) oligosaccharide on myocardial and cerebral injury in the pig.
M. Tofukuji
,
C. Métais
,
+6 authors
F. Sellke
Annals of Thoracic Surgery
1999
Corpus ID: 37814127
1999
1999
The sialyl Lewis X analogue, CY-1503, down-regulates leucocyte-endothelium interactions and the inflammatory response.
F. J. García-Criado
,
J. J. Valdunciel-Garcia
,
+6 authors
A. Gómez‐Alonso
The European journal of surgery = Acta chirurgica
1999
Corpus ID: 35767152
OBJECTIVE To elucidate mechanisms of protection of ischaemic liver with the sialyl Lewis X analogue CY-1503 by regulation of…
Expand
1997
1997
Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts.
R. Schmid
,
M. Yamashita
,
+5 authors
G. Patterson
The Journal of Heart and Lung Transplantation
1997
Corpus ID: 806251
BACKGROUND Neutrophil adhesion is initiated by the interaction of rapidly expressed endothelial selectins with oligosaccharide…
Expand
1997
1997
Protective role of synthetic sialylated oligosaccharide in sepsis-induced acute lung injury.
P. Ridings
,
S. Holloway
,
+5 authors
A. Fowler
Journal of applied physiology
1997
Corpus ID: 14235271
Proper engagement of leukocyte and endothelial cell selectins with their counterreceptors is an initial step in neutrophil…
Expand
1997
1997
Sialyl Lewis(x) analog improves liver function by decreasing neutrophil migration after hemorrhagic shock.
J. Rubio-Avilla
,
J. Palma-Vargas
,
+4 authors
L. Toledo-Pereyra
Journal of Trauma
1997
Corpus ID: 32411804
BACKGROUND Little is known about the changes in the hepatic microcirculation and the leukocyte-endothelial adhesion processes…
Expand
1996
1996
An oligosaccharide sialyl-Lewis(x) analogue does not reduce myocardial infarct size after ischemia and reperfusion in dogs.
E. Gill
,
Y. Kong
,
L. Horwitz
Circulation
1996
Corpus ID: 22142133
BACKGROUND Polymorphonuclear leukocytes, particularly neutrophils, are important mediators of ischemia/reperfusion-induced…
Expand
1996
1996
Role of sialyl Lewis(x) in total hepatic ischemia and reperfusion.
K. Misawa
,
L. Toledo-Pereyra
,
M. Phillips
,
F. J. Garcia-Cirado
,
F. López-Neblina
,
A. Páez-Rollys
Journal of the American College of Surgeons
1996
Corpus ID: 33513666
BACKGROUND Neutrophil adhesion and migration is associated with hepatic ischemia and reperfusion. The role of a Sialyl Lewis(x…
Expand
Highly Cited
1994
Highly Cited
1994
A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion.
D. Lefer
,
David M. Flynn
,
M. Phillips
,
Murray Ratcliffe
,
Andrew J. Buda
Circulation
1994
Corpus ID: 15862723
BACKGROUND Polymorphonuclear leukocytes (PMNs) have been shown to mediate coronary vascular and myocardial tissue injury after…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE